echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Microbiology News > The clinical research of Lactobacillus casei Zhang in improving kidney disease officially appeared in the publication

    The clinical research of Lactobacillus casei Zhang in improving kidney disease officially appeared in the publication

    • Last Update: 2021-10-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com






    Intestinal flora can affect the occurrence and development of kidney diseases through its metabolites and other mechanisms, and probiotics may be used for the prevention and treatment of kidney diseases
    .


    Cell Metabolism recently published research results from the team led by Professor Zeng Rui, Professor Yao Ying, and Professor Xu Gang from Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
    .
    Professor Zhang Heping from Inner Mongolia Agricultural University participated and signed it .


    The study, combined with mouse animal experiments and clinical trials, revealed the role and mechanism of intestinal flora imbalance and probiotic intervention in acute kidney injury and chronic kidney disease.
    It shows that supplementing Lactobacillus casei Zhang can improve the intestinal flora and increase Beneficial metabolites (such as short-chain fatty acids and nicotinamide) to reduce kidney damage and slow down the decline of renal function
    .
    The related results have clinical application prospects and are worthy of professional attention!


     

    Disclaimer: This article only represents the author's personal views and has nothing to do with China Probiotics.
    com
    .
    The originality and the text and content stated in the article have not been verified by this site.
    This site does not make any guarantee or commitment to the authenticity, completeness, and timeliness of this article, all or part of the content, and the text.
    Please readers for reference only, and please Verify the relevant content yourself
    .
     

    Copyright Notice

    1.
    Some of the reprinted articles on this site are not original, and the copyright and liability belong to the original author
    .
    2.
    All reprinted articles, links and pictures on this website are for the purpose of conveying more information, and clearly indicate the source and author.
    Media or individuals who do not want to be reprinted can contact us for infringement information that can provide sufficient evidence , Bio149 will be deleted within 12 hours after confirmation
    .
    3.
    Users are welcome to post original articles to 86371366@qq.
    com, and publish them to the homepage after review.
    The copyright and liability belong to the sender
    .




     
      Intestinal flora can affect the occurrence and development of kidney diseases through its metabolites and other mechanisms, and probiotics may be used for the prevention and treatment of kidney diseases
    .


      Cell Metabolism recently published research results from the team led by Professor Zeng Rui, Professor Yao Ying, and Professor Xu Gang from Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
    .
    Professor Zhang Heping from Inner Mongolia Agricultural University participated and signed it .


      The study, combined with mouse animal experiments and clinical trials, revealed the role and mechanism of intestinal flora imbalance and probiotic intervention in acute kidney injury and chronic kidney disease.
    It shows that supplementing Lactobacillus casei Zhang can improve the intestinal flora and increase Beneficial metabolites (such as short-chain fatty acids and nicotinamide) to reduce kidney damage and slow down the decline of renal function
    .
    The related results have clinical application prospects and are worthy of professional attention!


     

    Disclaimer: This article only represents the author's personal views and has nothing to do with China Probiotics.
    com
    .
    The originality and the text and content stated in the article have not been verified by this site.
    This site does not make any guarantee or commitment to the authenticity, completeness, and timeliness of this article, all or part of the content, and the text.
    Please readers for reference only, and please Verify the relevant content yourself
    .
     

    Copyright Notice

    1.
    Some of the reprinted articles on this site are not original, and the copyright and liability belong to the original author
    .
    2.
    All reprinted articles, links and pictures on this website are for the purpose of conveying more information, and clearly indicate the source and author.
    Media or individuals who do not want to be reprinted can contact us for infringement information that can provide sufficient evidence , Bio149 will be deleted within 12 hours after confirmation
    .
    3.
    Users are welcome to post original articles to 86371366@qq.
    com, and publish them to the homepage after review.
    The copyright and liability belong to the sender
    .




     
      Intestinal flora can affect the occurrence and development of kidney diseases through its metabolites and other mechanisms, and probiotics may be used for the prevention and treatment of kidney diseases
    .


      Cell Metabolism recently published research results from the team led by Professor Zeng Rui, Professor Yao Ying, and Professor Xu Gang from Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
    .
    Professor Zhang Heping from Inner Mongolia Agricultural University participated and signed it .


      The study, combined with mouse animal experiments and clinical trials, revealed the role and mechanism of intestinal flora imbalance and probiotic intervention in acute kidney injury and chronic kidney disease.
    It shows that supplementing Lactobacillus casei Zhang can improve the intestinal flora and increase Beneficial metabolites (such as short-chain fatty acids and nicotinamide) to reduce kidney damage and slow down the decline of renal function
    .
    The related results have clinical application prospects and are worthy of professional attention!


     

    Disclaimer: This article only represents the author's personal views and has nothing to do with China Probiotics.
    com
    .
    The originality and the text and content stated in the article have not been verified by this site.
    This site does not make any guarantee or commitment to the authenticity, completeness, and timeliness of this article, all or part of the content, and the text.
    Please readers for reference only, and please Verify the relevant content yourself
    .
     

    Copyright Notice

    1.
    Some of the reprinted articles on this site are not original, and the copyright and liability belong to the original author
    .
    2.
    All reprinted articles, links and pictures on this website are for the purpose of conveying more information, and clearly indicate the source and author.
    Media or individuals who do not want to be reprinted can contact us for infringement information that can provide sufficient evidence , Bio149 will be deleted within 12 hours after confirmation
    .
    3.
    Users are welcome to post original articles to 86371366@qq.
    com, and publish them to the homepage after review.
    The copyright and liability belong to the sender
    .



     
      Intestinal flora can affect the occurrence and development of kidney diseases through its metabolites and other mechanisms, and probiotics may be used for the prevention and treatment of kidney diseases
    .


      Cell Metabolism recently published research results from the team led by Professor Zeng Rui, Professor Yao Ying, and Professor Xu Gang from Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
    .
    Professor Zhang Heping from Inner Mongolia Agricultural University participated and signed it .


      The study, combined with mouse animal experiments and clinical trials, revealed the role and mechanism of intestinal flora imbalance and probiotic intervention in acute kidney injury and chronic kidney disease.
    It shows that supplementing Lactobacillus casei Zhang can improve the intestinal flora and increase Beneficial metabolites (such as short-chain fatty acids and nicotinamide) to reduce kidney damage and slow down the decline of renal function
    .
    The related results have clinical application prospects and are worthy of professional attention!

     
     
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.